Use of novel antiplatelet agents in acute coronary syndromes.

about

Use of novel antiplatelet agents in acute coronary syndromes.

Item

http://www.wikidata.org/entity/Q38348649

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Use of novel antiplatelet agents in acute coronary syndromes.

@en

type

Item

label

Use of novel antiplatelet agents in acute coronary syndromes.

@en

prefLabel

Use of novel antiplatelet agents in acute coronary syndromes.

@en

P1476

Use of novel antiplatelet agents in acute coronary syndromes.

@en

P2093

Elizabeth M Holper

http://www.w3.org/2001/XMLSchema#string

Michael Luna

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical profile of prasugrel, a novel thienopyridine

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Stent thrombosis in randomized clinical trials of drug-eluting stents

P2888

s11883-014-0483-4

P304

483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11883-014-0483-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000838828

http://www.w3.org/2001/XMLSchema#string

P698

25663559

http://www.w3.org/2001/XMLSchema#string

Use of novel antiplatelet agents in acute coronary syndromes.

about

Use of novel antiplatelet agents in acute coronary syndromes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698